Cancer Gene Therapy Market (By Type: Ex-vivo, In-vivo; By Product: Viral Vectors, Non-viral Vectors, Others; By End-use: Biopharma companies, Research Institutes, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Cancer Gene Therapy
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Cancer Gene Therapy Market By Type
     1.2.2.1. Global Cancer Gene Therapy Market Revenue and Growth Rate Comparison By Type (2015-2026)
     1.2.2.2. Global Cancer Gene Therapy Market Revenue Share By Type in 2017
     1.2.2.3. Ex-vivo
     1.2.2.4. In-vivo
     1.2.2.5. Others
   1.2.3. Cancer Gene Therapy Market By Product
     1.2.3.1. Global Cancer Gene Therapy Market Revenue and Growth Rate Comparison By Product (2015-2026)
     1.2.3.2. Global Cancer Gene Therapy Market Revenue Share By Product in 2017
     1.2.3.3. Viral Vectors
     1.2.3.4. Non-viral Vectors
     1.2.3.5. Others
   1.2.4. Cancer Gene Therapy Market By End-Use
     1.2.4.1. Global Cancer Gene Therapy Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
     1.2.4.2. Global Cancer Gene Therapy Market Revenue Share By End-Use in 2017
     1.2.4.3. Hospitals
     1.2.4.4. Biopharma companies
     1.2.4.5. Research Institutes
     1.2.4.6. Others
   1.2.5. Cancer Gene Therapy Market By Geography
     1.2.5.1. Global Cancer Gene Therapy Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.5.2. North America Cancer Gene Therapy Market Revenue and Growth Rate (2015-2026)
     1.2.5.3. Europe Cancer Gene Therapy Market Revenue and Growth Rate (2015-2026)
     1.2.5.4. Asia-Pacific Cancer Gene Therapy Market Revenue and Growth Rate (2015-2026)
     1.2.5.5. Latin America Cancer Gene Therapy Market Revenue and Growth Rate (2015-2026)
     1.2.5.6. Middle East and Africa (MEA) Cancer Gene Therapy Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Cancer Gene Therapy Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Cancer Gene Therapy Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Cancer Gene Therapy Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Cancer Gene Therapy Major Manufacturers in 2017

CHAPTER 4. CANCER GENE THERAPY MARKET By TYPE
4.1. Global Cancer Gene Therapy Revenue By Type
4.2. Ex-vivo
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. In-vivo
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CANCER GENE THERAPY MARKET BY PRODUCT
5.1. Global Cancer Gene Therapy Revenue By Product
5.2. Viral Vectors
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Non-viral Vectors
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. CANCER GENE THERAPY MARKET BY END-USE
6.1. Global Cancer Gene Therapy Revenue By End-Use
6.2. Hospitals
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Biopharma companies
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Research Institutes
   6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
   6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA CANCER GENE THERAPY MARKET BY COUNTRY
7.1. North America Cancer Gene Therapy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Cancer Gene Therapy Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
   7.3.1. U.S. Cancer Gene Therapy Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE CANCER GENE THERAPY MARKET BY COUNTRY
8.1. Europe Cancer Gene Therapy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Cancer Gene Therapy Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC CANCER GENE THERAPY MARKET BY COUNTRY
9.1. Asia-Pacific Cancer Gene Therapy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Cancer Gene Therapy Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   9.8.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.8.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA CANCER GENE THERAPY MARKET BY COUNTRY
10.1. Latin America Cancer Gene Therapy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Cancer Gene Therapy Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & Africa CANCER GENE THERAPY MARKET BY COUNTRY
11.1. Middle East & Africa Cancer Gene Therapy Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Cancer Gene Therapy Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Vigene Biosciences
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Product Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Sirion Biotech
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Product Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. Bluebird Bio
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Product Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Cellectis
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Product Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. Ziopharm
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Product Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. Cobra
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Product Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Finvector
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Product Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Sangamo Therapists Inc.
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Product Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Novartis AG
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Product Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Sarepta Therapeutics
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Product Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies
12.11. Caribou
   12.11.1. Company Snapshot
   12.11.2. Overview
   12.11.3. Financial Overview
   12.11.4. Product Portfolio
   12.11.5. Key Developments
   12.11.6. Strategies
12.12. Others
   12.12.1. Company Snapshot
   12.12.2. Overview
   12.12.3. Financial Overview
   12.12.4. Product Portfolio
   12.12.5. Key Developments
   12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope